188 related articles for article (PubMed ID: 31676306)
1. Synthesis of novel hybrid hetero-steroids: Molecular docking study augmented anti-proliferative properties against cancerous cells.
Mohamed SA; El-Kady DS; Abd-Rabou AA; Tantawy MA; AbdElhalim MM; Elazabawy SR; Abdallah AEM; Elmegeed GA
Steroids; 2020 Feb; 154():108527. PubMed ID: 31676306
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of Novel Cholestanoheterocyclic Steroids as Anticancer Agents.
El-Kady DS; Abd Rabou AA; Tantawy MA; Abdel-Rahman AA; Abdel-Megeed AA; AbdElhalim MM; Elmegeed GA
Appl Biochem Biotechnol; 2019 Jul; 188(3):635-662. PubMed ID: 30613863
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer potential of novel 5,6-oxygenated and/or halogenated steroidal d-homo lactones.
Kuzminac IZ; Jakimov DS; Bekić SS; Ćelić AS; Marinović MA; Savić MP; Raičević VN; Kojić VV; Sakač MN
Bioorg Med Chem; 2021 Jan; 30():115935. PubMed ID: 33340938
[TBL] [Abstract][Full Text] [Related]
4. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
5. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer activity, and molecular docking of novel hybrid heterocyclic steroids revealed promising anti-hepatocellular carcinoma agent: Implication of cyclin dependent kinase-2 pathway.
Tantawy MA; Shalby AB; Barnawi IO; Kattan SW; Abd-Rabou AA; Elmegeed GA
Steroids; 2023 May; 193():109187. PubMed ID: 36736802
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new steroidal imidazo [1,2-a] pyridines: DNA binding studies, cleavage activity and in vitro cytotoxicity.
Dar AM; Shamsuzzaman ; Gatoo MA
Steroids; 2015 Dec; 104():163-75. PubMed ID: 26433147
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
9. Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
Mantipally M; Gangireddy MR; Gundla R; Badavath VN; Mandha SR; Maddipati VC
Bioorg Med Chem Lett; 2019 Aug; 29(16):2248-2253. PubMed ID: 31239178
[TBL] [Abstract][Full Text] [Related]
10. DFT/B3LYP calculations, in vitro cytotoxicity and antioxidant activities of steroidal pyrimidines and their interaction with HSA using molecular docking and multispectroscopic techniques.
Ali A; Asif M; Alam P; Jane Alam M; Asif Sherwani M; Hasan Khan R; Ahmad S; Shamsuzzaman
Bioorg Chem; 2017 Aug; 73():83-99. PubMed ID: 28623723
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and antitumor activity evaluation of steroidal oximes.
Gomes AR; Pires AS; Abrantes AM; Gonçalves AC; Costa SC; Varela CL; Silva ET; Botelho MF; Roleira FMF
Bioorg Med Chem; 2021 Sep; 46():116360. PubMed ID: 34425478
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of steroidal imidazolidinthiones as potential apoptotic agents: Investigation by theoretical and experimental studies.
Dar AM; Nabi R; Mir S; Gatoo MA; Shamsuzzaman ; Lone SH
Bioorg Chem; 2018 Sep; 79():190-200. PubMed ID: 29772469
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors.
Parveen I; Khan P; Ali S; Hassan MI; Ahmed N
Eur J Med Chem; 2018 Nov; 159():166-177. PubMed ID: 30290280
[TBL] [Abstract][Full Text] [Related]
16. Novel Hybrid Molecules on the Basis of Steroids and (5Z,9Z)-Tetradeca-5,9-dienoic Acid: Synthesis, Anti-Cancer Studies and Human Topoisomerase I Inhibitory Activity.
D'yakonov VA; Dzhemileva LU; Tuktarova RA; Ishmukhametova SR; Yunusbaeva MM; Ramazanova IR; Dzhemilev UM
Anticancer Agents Med Chem; 2017; 17(8):1126-1135. PubMed ID: 27928953
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel 5α, 8α-endoperoxide steroidal derivatives with hybrid side chain as anticancer agents.
Li H; Wang H; Wang J; Lin Y; Ma Y; Bu M
Steroids; 2020 Jan; 153():108471. PubMed ID: 31400390
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity of two steroids: icogenin aglycone analogs.
Guan YY; Li SZ; Lei PS
J Asian Nat Prod Res; 2017 May; 19(5):481-488. PubMed ID: 28276770
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK
Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
[TBL] [Abstract][Full Text] [Related]
20. 3'-(4-(Benzyloxy)phenyl)-1'-phenyl-5-(heteroaryl/aryl)-3,4-dihydro-1'H,2H-[3,4'-bipyrazole]-2-carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies.
Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Pottoo FH; Jha M
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900262. PubMed ID: 32003485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
